Home
http://www.democracynow.org/2012/7/17/spying_on_scientists_how_the_fda
Dr. David Graham—another prominent FDA whistleblower who blew the lid on the Vioxx scandal—stated in a 2005 interview:
<blockquote>
“As currently configured, the FDA is not able to adequately
protect the American public. It's more interested in protecting the
interests of industry. It views industry as its client, and the client
is someone whose interest you represent. Unfortunately, that is the way
the FDA is currently structured.
Within the Center for Drug Evaluation and Research, about 80
percent of the resources are geared towards the approval of new drugs
and 20 percent is for everything else. Drug safety is about 5 percent.
The "gorilla in the living room" is new drugs and approval. Congress has
not only created that structure, they have also worsened that structure
through the PDUFA, the Prescription Drug User Fee Act, by which drug
companies pay money to the FDA so they will review and approve its
drug.”
</blockquote>
Dr. David Graham—another prominent FDA whistleblower who blew the lid on the Vioxx scandal—stated in a 2005 interview:
<blockquote>
“As currently configured, the FDA is not able to adequately
protect the American public. It's more interested in protecting the
interests of industry. It views industry as its client, and the client
is someone whose interest you represent. Unfortunately, that is the way
the FDA is currently structured.
Within the Center for Drug Evaluation and Research, about 80
percent of the resources are geared towards the approval of new drugs
and 20 percent is for everything else. Drug safety is about 5 percent.
The "gorilla in the living room" is new drugs and approval. Congress has
not only created that structure, they have also worsened that structure
through the PDUFA, the Prescription Drug User Fee Act, by which drug
companies pay money to the FDA so they will review and approve its
drug.”
</blockquote>